 |
|
|
| |
Efficacy of dolutegravir plus lamivudine in treatment-naive people living with HIV without baseline drug-resistance testing: week 24 results of the randomized D2ARLING study
|
| |
| |
IAS 2023 july 25
E. Cordova1, J. Hernandez Rendon1, V. Mingrone1, P. Martin1, G. Arevalo Calderon1, J. Ballivian1, S. Seleme1, N. Porteiro1 1Fundacion IDEAA, Research Department, Buenos Aires, Argentina
|
| |
|
|
|
|
|
